SALL4 and neoplasm: To test whether knocking down SALL4 would also lead to decreased tumor growth of human xenografts in vivo, we next injected human melanoma cells 24 h after siRNA transfection subcutaneously into nude mice and analyzed tumor growth within 6 days after grafting.